https://www.selleckchem.com/products/ars-853.html
To investigate the effects of early upstream antithrombotic therapy administration (ATTA) in ST-segment elevation myocardial infarction (STEMI) patients with prolonged transport times to primary percutaneous intervention (PPCI) on major clinical outcomes. It remains unclear whether early upstream administration of aspirin, ticagrelor, and unfractionated heparin (UFH) confers additional benefits compared with in-hospital administration. Between 2015 and 2018, we performed PPCI in 709 included consecutive STEMI patients. We compared 482 S
Like
Comment
Share
